SIGA Technologies Inc.
Follow $SIGA
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SIGA by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is SIGA moving today?
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
SIGA overview
Related filings and maps
Congress activity in SIGA
No receipt-qualified Congressional disclosure is present for SIGA in the cached public ledger.
SIGA contract awards, year to date.
Public federal awards linked to this ticker.
SIGA lobbying filings, year to date.
Registered lobbying filings matched to SIGA Technologies Inc..